Eosinophilic Cystitis Mimicking Urothelial Neoplasia

Status Completed

Clinical Trial Summary

We explored the potential etiology, clinical and histopathology presentation of the eosinophilic cystitis cases, clinically mimicking urothelial neoplasia. Surgical procedure and clinical outcome also evaluated. T

Clinical Trial Description

A pooled 22 patients diagnosed with eosinophilic cystitis on microscopic examination in our hospital during four years were retrospectively studied.We explored the potential etiology, clinical and histopathology presentation of the eosinophilic cystitis cases, clinically mimicking urothelial neoplasia. Surgical procedure and clinical outcome also evaluated. Transurethral resection of the lesions were performed and pathologically examined, we re-examined the studied cases and made a clinical correlation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04914442
Study type	Observational
Source	Al-Azhar University
Contact
Status	Completed
Phase
Start date	January 17, 2017
Completion date	January 20, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02320773` - A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
Completed	`NCT03081858` - Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer	Phase 1/Phase 2
Recruiting	`NCT05250908` - INTIBIA Pivotal Study	N/A
Completed	`NCT01340027` - A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder	Phase 2
Recruiting	`NCT04922047` - Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)	Phase 1/Phase 2
Completed	`NCT01638000` - A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.	Phase 3
Completed	`NCT04161716` - Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans (DETTECH)	N/A
Completed	`NCT01908829` - A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)	Phase 3
Recruiting	`NCT04442724` - Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy	N/A
Completed	`NCT02386072` - A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Completed	`NCT02891460` - Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients	N/A
Terminated	`NCT00384891` - Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer	Phase 3
Recruiting	`NCT06237920` - Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab	Phase 2
Completed	`NCT03845725` - Falls and Balance of Patients With Parkinson's Disease With Urinary Disturbance
Completed	`NCT02307487` - Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients	Phase 2
Recruiting	`NCT05153694` - Infectious Complications After Cystectomy: A Prospective Observational Study
Completed	`NCT01930799` - Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns	Phase 4
Terminated	`NCT01060254` - A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain	Phase 2
Not yet recruiting	`NCT05643963` - The COOKER-BLADDER Trial	N/A
Active, not recruiting	`NCT03245242` - Pediatric Urology Recovery After Surgery Endeavor (PURSUE)